Carotid Artery Surgery for Cervical Lymph Node Invasion: Limitations of Neck Dissection

Research Article

Austin J Otolaryngol. 2015; 2(7): 1056.

Carotid Artery Surgery for Cervical Lymph Node Invasion: Limitations of Neck Dissection

Furusaka T1,2*, Asakawa T¹, Hasegawa H¹, Shigihara S¹ and Matsuda H²

¹Department of Otolaryngology-Head and Neck Surgery, Nihon University School of Medicine, Japan

²Laboratory of Veterinary Molecular Pathology and Therapeutics, Division of Animal Life Science, Tokyo University of Agriculture and Technology, Japan

*Corresponding author: Tohru Furusaka, Department of Otolaryngology-Head and Neck Surgery, Nihon University School of Medicine, 30-1 Oyaguchi-kami-cho, Itabashi-ku, Tokyo 173-8610, Japan

Received: December 01, 2014; Accepted: September 05, 2015; Published: September 07, 2015

Abstract

Objectives/Hypothesis: To evaluate reconstructive surgery of the common carotid artery; and to investigate the indications for this treatment, the limitations of neck dissection as treatment, and the feasibility of concurrent chemoradiation therapy (CCRT).

Study Design: Retrospective observational study.

Methods: Forty-four patients underwent reconstructive surgery of carotid artery concurrently in radical neck dissection. Twelve patients did not undergo carotid artery reconstruction, 7 underwent reconstruction using a polytetrafluoroethylene (PTFE) graft, 11 underwent reconstruction using an autologous great saphenous vein graft, and 14 underwent vein patch angioplasty after partial resection of the carotid artery.

Results: All 7 patients who received PTFE grafts and 11 patients who received saphenous vein grafts died within 2 years after surgery. Four of the 12 patients who did not undergo carotid artery reconstruction and 5 of the 14 patients who underwent vein patch angioplasty survived for 5 years.

Conclusion: Patients who underwent neck dissection with reconstructive surgery of the carotid artery had a poor prognosis. Patients who underwent carotid artery resection without reconstruction followed by postoperative radiation therapy survived. CCRT without surgery should be considered in patients with N3 cases.

Keywords: PTFE graft; Great saphenous vein; Resection without reconstruction; Patch angioplasty; Concurrent chemoradiation therapy

Introduction

In patients with advanced head and neck cancer, surgical excision of the primary site often causes severe functional and aesthetic damage. We have achieved high rates of organ preservation and overall survival by treatment of these patients with chemotherapy in combination with complete regional lymph node dissection. Our chemotherapy regimen includes two cycles of intra-arterial docetaxel and cisplatin plus continuous intravenous infusion of 5-fluorouracil for 5 days starting on day 2, followed by two cycles of concurrent chemoradiation therapy (CCRT) [1-4].

The ability to control cervical lymph node metastasis significantly affects the prognosis of patients with head and neck cancer. The current technique of radical neck dissection including resection of the internal jugular vein, sternocleidomastoid muscle, and accessory nerve was established in 1933 [5]. To our knowledge, however, there have been no reports addressing the optimal extent of dissection. In 1905, Crile, who first described systematic neck dissection, recommended temporary clamping of the carotid artery to reduce blood loss, but did not describe the results of this technique [6]. We often encounter invasion of metastatic lymph nodes into the common carotid artery, but the optimal management of such invasion is currently unclear.

We reviewed outcomes in patients with invasion of metastatic lymph nodes into the common carotid artery who underwent carotid artery resection during radical neck dissection, according to the carotid artery reconstruction technique used. The indications for carotid artery reconstruction surgery are reviewed, and the optimal treatment of patients with N3 disease is discussed.

Materials and Methods

Patients

This study included 44 patients with primary squamous cell carcinoma of the head and neck (Table 1). The patients were 35 males and 9 females with a mean age of 58.6 years (median 59 years, range 39–69 years). The primary site was the oropharynx in 16 patients, hypopharynx in 16 patients, and larynx in 12 patients. Preoperative treatment was by radiation therapy alone in 11 patients, chemotherapy alone in 11 patients, and chemoradiation therapy in 22 patients.